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Abstract
Background: The conduct of randomized controlled trials (RCTs) in low-resource settings may present unique
financial, logistic, and process-related challenges. Middle-income countries that have comparable disease burdens
to low-income countries, but greater availability of resources, may be conducive settings for RCTs. Indeed, the
country of Botswana is experiencing a rapid increase in the conduct of RCTs. Our objective was to explore the
experiences of individuals conducting RCTs in Botswana to gain an understanding of the challenges and adaptive
strategies to their work.
Methods: We conducted in-depth interviews with 14 national and international individuals working on RCTs
in Botswana. Participants included principal investigators, research coordinators, lab technicians, research
assistants, and other healthcare professionals. Interviews were audiotaped, transcribed verbatim, and coded for
thematic analysis.
Results: Five primary themes were identified: ethics board relationships (including delays in the process);
research staff management (including staff attrition and career development); study recruitment and retention
(including the use of reimbursements); resource availability (including challenges accessing laboratory
equipment); and capacity-building (including issues of exporting locally sourced samples). These themes were
explored to discuss key challenges and adaptive strategies.
Conclusions: This study offers a first-hand account of individuals engaged in conducting RCTs in Botswana, a
nation that is experiencing a rapid increase in research activities. Findings provide a foundational
understanding for researchers in Botswana and trial managers in similar settings when planning RCTs so that
the conduct of research does not outpace the ability to manage, support, and regulate it.

Background
The randomized controlled trial (RCT) is critical to exploring the impact of interventions and is the ideal study
design to establish causality [1]. Unique to the RCT design
is the random assignment of participants to a treatment
or intervention group, which reduces the potential for systematic biases that may compromise internal validity in
observational epidemiologic studies [2]. RCTs have been
critical to advancing public health and clinical research;
many important medical treatments such as the wellknown HIV drug, Tenofovir, have only been approved for
population-wide use after a long series of RCTs [3].
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The advantages of the RCT design have led to its
widespread use. However, the conduct of RCTs in regions of the world with limited research capacity may
present financial, logistic, and process-related challenges.
For example, investigators in Lebanon faced barriers in
enrollment that stemmed from misconception about unfamiliar terms such as “randomization” [4]. In Peru, researchers found that community members were hesitant
to sign study consent forms due to cultural resistance to
foreign documents as a result of past instances of land
being unjustly seized by foreigners [5]. These few examples tell a greater narrative of cultural and linguistic
challenges associated with the conduct of research in
global settings. Studies have examined the utility of dedicated trial managers, individuals tasked with managerial
and scientific duties, as critical to the success of trials
[6]. However, that role is not standard in all studies.
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It is critical to identify the factors that promote the conduct of high-quality RCTs, especially in regions of the
world currently experiencing an increase in research activities. Botswana – a country in southern Africa – has
undergone this exponential growth, particularly in clinical
trials. This increase in research capacity may be attributed
to the fact that while Botswana is an upper middleincome country, its diseases of burden such as HIV/AIDS
and tuberculosis, are similar to that of low-income countries [7, 8]. Indeed, numerous research partnerships have
formed between Botswana institutions and U.S. institutions to address these diseases, such as the: Botswana–
UPenn Partnership, Botswana–Harvard Partnership, and
Gates Foundation’s African Comprehensive HIV/AIDS
Partnership [9–11]. This convergence of international
partnerships and the Botswana government’s investment
to support research has created a unique opportunity to
not only do clinical trials, but also to study the conduct of
RCTs in Botswana. Previous studies have primarily focused on the need for improved quality management systems and resource constraints in the region [12, 13]. This
study aims to provide a qualitative account from individuals who are involved in the day-to-day conduct of trials
in Botswana. Results would provide key insights for researchers who are engaged in Botswana and might provide
a foundational understanding for those in similar settings.

Methods
This qualitative study was conducted between June and October 2016 and was approved by the University of Pennsylvania Institutional Review Board (IRB) and the Botswana
Health Research Development Committee (HRDC).
Participant selection and data collection

We employed a snowball sampling approach to recruit respondents. To do so, the research team identified a contact organization (Botswana–UPenn Partnership) who
then connected the first author with potential participants,
some of whom facilitated additional contacts. Individuals
were eligible for inclusion if they were involved in the previous or current conduct of RCTs in the catchment area
of Gaborone, Botswana. The only restriction on participation was on distance from Gaborone, as recruiting nationwide would have posed logistic difficulties for interviews.
Potential participants were first contacted via email in
June 2016, with an additional email invitation two weeks
later. Individuals who failed to reply to the contact attempts were assumed to have declined to participate in
the study. Respondents were interviewed either in person
or by telephone by the first author (JMB) in a private
space away from the individual’s immediate work area, in
order to maximize the privacy of the respondent. All
interviews were audiotaped, transcribed verbatim, and deidentified.

Page 2 of 6

Qualitative interview instrument

The interview instrument was a semi-structured guide
consisting of open-ended questions. All interviews were
conducted in English with English-speaking respondents;
thus, no translator was necessary. The interview guide included questions on RCT experience in Botswana and key
aspects of the research process such as the IRB approval
and participant recruitment and follow-up. This guide was
piloted through mock interviews with volunteers prior to
engaging the intended participants. Interviews were
estimated to take 1 h. As is customary in qualitative
research, early interviews informed amendments to
the guide through an iterative process to explore additional areas of interest. The study team met monthly
throughout the data collection period to assess saturation and quality control.
Analytic approach

The research team employed a directed content analysis
approach through which codes were developed in two
ways: a priori (informed by the interview guide) and
through line-by-line reading of five representative transcripts [14]. Each code was given an explicit definition in
the codebook to ensure coding accuracy. The first author (JMB) independently coded all transcripts and a
coding audit of four of the 14 transcripts was completed by the senior author (RF) to assess coding accuracy; percent agreement was assessed (range 98–100%).
The analysis of the transcripts was facilitated by NVivo,
a qualitative software analysis program [15].

Results
Fourteen key informants participated in this study and
their characteristics are described in Table 1. Their roles
on the trial team included: principal investigator (n = 6);
research coordinator (n = 2); laboratory technician (n =
2); research assistant (n = 3); and other healthcare professional (n = 1). Common themes dominated after 14
interviews, suggesting data saturation. The respondents
had varying number of research projects conducted, ranging from one trial to twelve.
Analysis revealed the following thematic categories:
ethics approval; research staff management; study recruitment and retention; and resource availability and
capacity-building. Data were then explored to identify
the challenges within these codes and the adaptive strategies used by respondents, when possible, to navigate
these challenges. These findings are described below
with selected quotations identified by indentation and
italicized text.
Ethics approval

Respondents explained that the first step in conducting
a study in Botswana is seeking ethics approval from the
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Table 1 Characteristics of key informants
Respondents

n

Overall

14

Column %

Sex
Male

6

43

Female

8

57

USA

7

50

Botswana

5

36

Other

2

14

Principal investigators

6

43

Other healthcare professional

1

7

Research coordinators

2

14

Laboratory technicians

2

14

Research assistants

3

22

10

72

4–7

2

14

8+

2

14

Nationality

Role in research

Research staff management

Trials conducted (n)
1–3

Despite these issues, respondents spoke of the benefits
that have come from the HRDC, such as a mandate that
research conducted by foreign investigators must include
local collaborators. Most respondents felt that these
partnerships with local collaborators greatly enriched
their studies. They reported that local collaborators
bring valuable knowledge from the community, informing teams on methods to increase acceptability of studies
in the community. However, other respondents believe
the mandate put too many demands on the few available
local investigators, preventing meaningful collaborations.

country’s institutional review board, the Health Research
Development Committee (HRDC). Though their role is
important in regulating studies in the country, many respondents discussed that the voluntary nature of the
HRDC, whose reviewers have primary clinical and academic responsibilities, has led to significant delays in
processing applications. As a result, there are no defined
timeline for approval processes in the way that the USA
or UK has, with some respondents citing periods a range
of 6–9 months for determinations.
Respondents shared that the opening of the University
of Botswana’s (UB) IRB has eased some delays in protocol processing by the HRDC, as the HRDC automatically
approves any protocol approved by UB. However, some
respondents still feel that there needs to be more done
to accommodate the large volume of protocols. One respondent shared that upon a visit to the HRDC, he
found that the delays in processing were due to a misplacement of his submission, as all submissions are handled in paper. Another respondent suggested that the
HRDC should consider instituting financial incentives
for the services of the reviewers, to encourage protocol
determinations in a timely manner.
What they need to do is invest some money in
reform of the HRDC to fix it. Some countries
charge money per protocol, I’m not saying that
helps, but… I think they ask a lot of people’s time,
so it’s hard to get people to engage in it. (Principal
investigator)

After gaining approval from the HRDC, the next phase
of conducting a RCT is assembling research staff. Respondents frequently described issues of staff retention
as a barrier to the conduct of research. Respondents reported that, as a result of short contracts, usually 6–9
months in length, tensions about job security have come
to the forefront for staff. While employers assumed the
issue of staff retention was a result of the short contracts, staff attributed the turnover to the lack of career
growth opportunities within some research partnerships.
When people leave [the bosses] don’t know why. People
are leaving because they don’t see career development.
You’re kind of stagnant. You don’t really advance.
(Laboratory technician)
As high turnover of staff is costly to the study in terms
of time and money, respondents shared some practices
that are aiding in staff retention. One respondent acknowledged that some research partnerships offer bonuses, referred to as “gratuity,” for those who complete
their contracts. This gratuity encourages staff who may
be otherwise looking for longer contracts not to leave
the study prematurely. Additionally, respondents discussed the career development initiatives some research
partnerships use to retain staff and build capacity. Respondents described that these initiatives include professional training seminars and routes for staff to pursue
advanced degrees.
Study recruitment and retention

After receiving necessary approval and assembling staff
and research resources, the success of a study rests on
designing and implementing effective recruitment and
retention strategies. Respondents generally suggested
moving away from passive forms of recruitment, such as
admissions forms that are not always updated. Instead,
respondents advocated that a more active form of recruitment, such as hiring specific recruitment staff, alleviated the burden from hospital nurses and physicians
and improved recruitment rates. Respondents also found
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that integrating technology into the study enrollment
process aided recruitment. One respondent shared that
since the introduction of tablet technology to her enrollment process, she has been able to increase the speed at
which she enrolls participants and, as a result, she has
been able to recruit three times as many patients as before. However, these changes to support recruitment
could come with unintended consequences. One respondent shared the misconception among some colleagues that effective recruitment was associated to the
termination of employment.
The person who I was working with had a very bad
belief about research. They had the belief that if you
are working in research, if you recruit more you will
reach the target quickly and then you will be jobless.
(Research coordinator)
The most commonly referenced strategy to study recruitment and retention that was recommended by respondents was the use of reimbursements to offset the
personal cost incurred for study participants. Respondents
felt that compensating study participants for their time
was a sign of respect and removed barriers to participating, such as travel. Though compensation increases retention, some respondents believed that monetary incentives
could be coercive to study participants. To navigate this
tension, a respondent shared that she only reveals the
availability of reimbursements after an individual has
expressed interest in the study.
Sometimes we use [compensation] as part of recruitment.
It should be the last thing. After probing whether I’m
interested or not, then at the end you can say… don’t
worry about coming here, because I’m going to give you
transport money. (Other healthcare professional)
Respondents explained that for some community members, research was a means to supplement income. One
respondent recalled that participants would show up outside of their scheduled follow-up appointments because
they were short on money and knew they would be given
a reimbursement. Another respondent talked about participants who were selling study drugs, unaware of their
randomization group (placebo or drug) and jeopardizing
the health of others as well as the study results.
Participants were very tricky… [they] were selling the
drugs. And what was paining me was that they were not
aware if they were taking the drug or the placebo. So,
they would be selling to HIV-positive people, they would
be coming with many stories: I was in a taxi, my drugs
are taken… or I put them in the house, maybe the relatives took it. (Other healthcare professional)
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Resource availability and capacity-building

As Botswana continues to engage in rigorous research, resource availability and capacity-building remain high-level
challenges to the conduct of RCTs. Resource availability,
in particular, was highlighted by many respondents. Respondents recalled study setbacks due to poor infrastructure and challenges accessing specialized laboratory
equipment. One adaptive strategy that respondents use to
circumvent these issues has been the sharing and coordination of resources by different research partnerships.
These resources include facilities, equipment, and staff,
which they singled out as the largest cost of any study.
Another respondent asserted that foreign researchers
working in low-resource settings should assume the responsibility to improve local research capacity. To do so,
the respondent spoke against the practice of exporting
locally collected study samples internationally for analysis. The respondent also suggested a policy for the
HRDC that would require researchers to send local research staff abroad when samples are exported, so that
they may learn more about the techniques being used.
I don’t think it’s quite right to take Batswana samples
out of Botswana. I have a fundamental issue with
samples collected from one country and taken to
another, without any justifiable reason except
convenience. (Laboratory technician)

Discussion
This paper offers an important perspective on research
activities in Botswana and adds to the growing literature
useful for trial managers conducting RCTs in all settings.
Though respondents in our study worked with standard
operating procedures, they discussed challenges in the
“unwritten” parts of the protocol, such as ethics approval, staff management, and protocol adherence. Prior
studies investigating the conduct of RCTs have reported
similar challenges.
Clinical trial managers have recognized the inefficiencies that lie in reinventing the trial management wheel
and suggest producing standard trial management guidelines to reduce those challenges. These standard guidelines would include the utilization of a trial manager in
designing the study, assuring data quality, and ensuring
that recruitment is realistic, practical, and ongoing [6]. A
2007 analysis of 114 multicenter trials found that less
than one-third of trials recruited their original target
within the time originally specified [16]. Clinical trial
unit directors in the UK reported that improvements to
trial recruitment, including methods to minimize attrition, were their highest priority [17]. Respondents in our
study also highlighted recruitment and retention as a
priority, sharing helpful strategies such as community
collaboration in designing study advertisements and the
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provision of reimbursements. The use of reimbursements, however, were variable among our respondents,
with some presenting it at differing points in the recruitment process (beginning or end). This type of variability
may not only affect recruitment rates, but may also contribute to a differential selection bias.
Other studies have found success in recruiting from
diverse populations when they integrate knowledge
from local collaborators such as an RCT of indigenous people in four countries (New Zealand, Australia,
Canada, and the United States). The inclusion of local
collaborators, integration of community engagement
groups to inform key study decisions, and the incorporation of local staff were strategies that our respondents also found to facilitate recruitment and
retention [18]. Other factors that have been associated
with good trial recruitment include having a dedicated trial manager, being a drug trial, and trials that
address clinically important questions at a timely
point [16]. Collectively, these studies highlight the importance of the role of local trial managers who are
able to work collaboratively with partners in foreign
settings.
This paper also uncovered issues of non-adherence to
treatment protocols that threaten to undermine the
RCT design. A review of 100 RCT publications from the
BMJ, New England Journal of Medicine, the Journal of
the American Medical Association, and The Lancet
found that 98% of the trials studied reported nonadherence to treatment protocols [19]. The review found
that adherence to randomized intervention is poorly
considered in the reporting and analysis of published
RCTs and often simply labeled as modified intention to
treat. While researchers are still struggling on methods
to optimize adherence, it is likely that using trial managers to investigate the causal factors of non-adherence
could aid in the challenge.
Along with issues of study recruitment and ethics
approval, the concept of capacity-building has been
on the forefront of those engaging in international research. In our study, respondents identified tensions
from behaviors such as exporting locally derived samples and the lack of career development as hindrances
of capacity-building. The required capacity-building
measures are diverse. Some efforts to build capacity
in African countries experiencing a progressive rise in
clinical trials include the creation of data safety monitoring boards to assist local researchers [20, 21].
These boards contribute to capacity-building as they
train nationals in data safety monitoring and research
skills training for research staff. It is critical for future
work to encourage and evaluate such measures to establish progresses and shortcomings in capacitybuilding. Overall, we are encouraged by the adaptive
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strategies that respondents described and believe it is
imperative that the conduct of research not only contributes to the generation of knowledge, but also to
the strengthening of research systems.

Strengths and limitations

The primary strength of this study is its inclusion of
individuals representing a variety of roles within the
trial team, resulting in a comprehensive collection of
perspectives. This led to the collection of many
themes, each of which can be further explored
through subsequent studies (e.g. a study that narrowly
focuses on exporting locally derived samples). Nonetheless, our findings must be considered in light of
some limitations. In terms of transferability, we interviewed a convenience sample of individuals working
on RCTs near the capital of Botswana, Gaborone.
Though we believe this study can provide foundational understanding for researchers dealing with universal issues such as staffing, ethics approval, and
recruitment, different regions may yield additional
challenges and, thus, may reveal new adaptive practices. A final limitation rests in the exploratory nature
of the study, as the authors are not currently based
in Botswana with extensive work in the region, but
rather, partnered with colleagues of the Botswana–
UPenn Partnership to conduct this study. That said,
this partnership served as a strength for this study as
we were able to navigate our own ethics approval
with guidance from nationally based research staff.
Additionally, as we stated before, this partnership
aided in our recruitment by providing us a platform
to communicate with other researchers and research
partnerships in the area.

Conclusion
RCTs are a research design that is widely used to
critically evaluate clinical treatments and interventions. This study assesses the conduct of RCTs in
Botswana and provides meaningful, front-line data
that can be shared with those working and regulating research in the region. Trial managers may find
insight from this context that may be applicable to
and potentially improve in their own trials. It is recommended that investigators systematically chronicle
these experiences in papers to directly inform the
work of the larger research community. This practice
would have tremendous value for individuals who
are engaged in building capacity in research infrastructure in global settings so that the conduct of
research does not outpace the ability to manage,
support, and regulate it.
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